BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ambade A, Lowe P, Kodys K, Catalano D, Gyongyosi B, Cho Y, Iracheta-Vellve A, Adejumo A, Saha B, Calenda C, Mehta J, Lefebvre E, Vig P, Szabo G. Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice. Hepatology 2019;69:1105-21. [PMID: 30179264 DOI: 10.1002/hep.30249] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou S, Tan Q, Wen B, Bai Y, Che Q, Cao H, Guo J, Su Z. Galacto-Oligosaccharide Alleviates Alcohol-Induced Liver Injury by Inhibiting Oxidative Stress and Inflammation. Metabolites 2022;12:867. [DOI: 10.3390/metabo12090867] [Reference Citation Analysis]
2 Ma J, Kumar V, Mahato RI. Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease. Pharmaceutics 2022;14:1894. [DOI: 10.3390/pharmaceutics14091894] [Reference Citation Analysis]
3 Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Commun (Lond) 2022. [PMID: 36069342 DOI: 10.1002/cac2.12345] [Reference Citation Analysis]
4 Xu W, Wu M, Chen B, Wang H. Myeloid cells in alcoholic liver diseases: Mechanism and prospect. Front Immunol 2022;13:971346. [DOI: 10.3389/fimmu.2022.971346] [Reference Citation Analysis]
5 Hyun JY, Kim SK, Yoon SJ, Lee SB, Jeong JJ, Gupta H, Sharma SP, Oh KK, Won SM, Kwon GH, Cha MG, Kim DJ, Ganesan R, Suk KT. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease. Int J Mol Sci 2022;23:8749. [PMID: 35955885 DOI: 10.3390/ijms23158749] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhu L, Li H, Xu J, Li J, Cheng M, Meng X, Huang C, Li J. Advancements in the Alcohol-Associated Liver Disease Model. Biomolecules 2022;12:1035. [DOI: 10.3390/biom12081035] [Reference Citation Analysis]
7 Moreno Traspas R, Teoh TS, Wong PM, Maier M, Chia CY, Lay K, Ali NA, Larson A, Al Mutairi F, Al-Sannaa NA, Faqeih EA, Alfadhel M, Cheema HA, Dupont J, Bézieau S, Isidor B, Low DY, Wang Y, Tan G, Lai PS, Piloquet H, Joubert M, Kayserili H, Kripps KA, Nahas SA, Wartchow EP, Warren M, Bhavani GS, Dasouki M, Sandoval R, Carvalho E, Ramos L, Porta G, Wu B, Lashkari HP, AlSaleem B, BaAbbad RM, Abreu Ferrão AN, Karageorgou V, Ordonez-Herrera N, Khan S, Bauer P, Cogne B, Bertoli-Avella AM, Vincent M, Girisha KM, Reversade B. Loss of FOCAD, operating via the SKI messenger RNA surveillance pathway, causes a pediatric syndrome with liver cirrhosis. Nat Genet 2022. [PMID: 35864190 DOI: 10.1038/s41588-022-01120-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wakil A, Niazi M, Meybodi MA, Pyrsopoulos NT. Emerging Pharmacotherapies in Alcohol-associated Hepatitis (AH). Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.06.012] [Reference Citation Analysis]
9 Li X, Jin X, Wang J, Li X, Zhang H. Dexamethasone attenuates dry eye-induced pyroptosis by regulating the KCNQ1OT1/miR-214 cascade. Steroids 2022;:109073. [PMID: 35779698 DOI: 10.1016/j.steroids.2022.109073] [Reference Citation Analysis]
10 Li W, Chang N, Li L. Heterogeneity and Function of Kupffer Cells in Liver Injury. Front Immunol 2022;13:940867. [DOI: 10.3389/fimmu.2022.940867] [Reference Citation Analysis]
11 Chen L, Kong D, Xia S, Wang F, Li Z, Zhang F, Zheng S. Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis. Front Pharmacol 2022;13:891069. [PMID: 35656309 DOI: 10.3389/fphar.2022.891069] [Reference Citation Analysis]
12 Szabo G, Thursz M, Shah VH. Therapeutic advances in alcohol-associated hepatitis. J Hepatol 2022;76:1279-90. [PMID: 35589250 DOI: 10.1016/j.jhep.2022.03.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Li Z, Dong J, Wang M, Yan J, Hu Y, Liu Y, Pan Y, Li H. Resveratrol ameliorates liver fibrosis induced by nonpathogenic Staphylococcus in BALB/c mice through inhibiting its growth. Mol Med 2022;28:52. [PMID: 35508992 DOI: 10.1186/s10020-022-00463-y] [Reference Citation Analysis]
14 Chen J, Wang M, Zhang P, Li H, Qu K, Xu R, Guo N, Zhu H. Cordycepin alleviated metabolic inflammation in Western diet-fed mice by targeting intestinal barrier integrity and intestinal flora. Pharmacol Res 2022;:106191. [PMID: 35346845 DOI: 10.1016/j.phrs.2022.106191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Sun X, Wu J, Liu L, Chen Y, Tang Y, Liu S, Chen H, Jiang Y, Liu Y, Yuan H, Lu Y, Chen Z, Cai J. Transcriptional switch of hepatocytes initiates macrophage recruitment and T cell suppression in endotoxemia. J Hepatol 2022:S0168-8278(22)00136-2. [PMID: 35276271 DOI: 10.1016/j.jhep.2022.02.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Barnault R, Verzeroli C, Fournier C, Michelet M, Redavid AR, Chicherova I, Plissonnier ML, Adrait A, Khomich O, Chapus F, Richaud M, Hervieu M, Reiterer V, Centonze FG, Lucifora J, Bartosch B, Rivoire M, Farhan H, Couté Y, Mirakaj V, Decaens T, Mehlen P, Gibert B, Zoulim F, Parent R. Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation. Hepatology 2022. [PMID: 35253915 DOI: 10.1002/hep.32446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang L, Bao Y, Tong H, Zhang K, Cheng Y, Jin H, Shi J, Wang T, Wang H, Chen G, Wang C. Traditional Mongolian medicine (HHQG) attenuates CCl4-induced acute liver injury through inhibiting monocyte/macrophage infiltration via the p-P38/p-JNK pathway. J Ethnopharmacol 2022;:115152. [PMID: 35240240 DOI: 10.1016/j.jep.2022.115152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 She S, Ren L, Chen P, Wang M, Chen D, Wang Y, Chen H. Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease. Front Immunol 2022;13:812431. [DOI: 10.3389/fimmu.2022.812431] [Reference Citation Analysis]
19 Yin F, Wu MM, Wei XL, Ren RX, Liu MH, Chen CQ, Yang L, Xie RQ, Jiang SY, Wang XF, Wang H. Hepatic NCoR1 deletion exacerbates alcohol-induced liver injury in mice by promoting CCL2-mediated monocyte-derived macrophage infiltration. Acta Pharmacol Sin 2022. [PMID: 35149852 DOI: 10.1038/s41401-022-00863-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Lotersztajn S, Riva A, Wang S, Dooley S, Chokshi S, Gao B. Inflammation in alcohol-associated liver disease progression. Z Gastroenterol 2022;60:58-66. [PMID: 35042254 DOI: 10.1055/a-1714-9246] [Reference Citation Analysis]
21 Liu M, Zhang H, Zhang L, Liu X, Zhou S, Wang X, Zhong W, Zhang J, Wang B, Zhao J, Zhou L. RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism. Int J Biol Sci 2022;18:199-213. [PMID: 34975327 DOI: 10.7150/ijbs.65402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Xu H, Wang H. Immune cells in alcohol-related liver disease. Liver Research 2022. [DOI: 10.1016/j.livres.2022.01.001] [Reference Citation Analysis]
23 Song Z, Gong Q, Guo J. Pyroptosis: Mechanisms and Links with Fibrosis. Cells 2021;10:3509. [PMID: 34944017 DOI: 10.3390/cells10123509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sun P, Zhong J, Liao H, Loughran P, Mulla J, Fu G, Tang D, Fan J, Billiar TR, Gao W, Scott MJ. Hepatocytes Are Resistant to Cell Death From Canonical and Non-Canonical Inflammasome-Activated Pyroptosis. Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00247-2. [PMID: 34890842 DOI: 10.1016/j.jcmgh.2021.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
25 Li G, Zhang Q, Han Z, Zhu Y, Shen H, Liu Z, Zhou Z, Ding W, Han S, He J, Yin Z, Zhou J, Ou R, Luo M, Liu S. IL-7 and CCR2b Co-Expression-Mediated Enhanced CAR-T Survival and Infiltration in Solid Tumors. Front Oncol 2021;11:734593. [PMID: 34778046 DOI: 10.3389/fonc.2021.734593] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Conte E. Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches. Pharmacol Ther 2021;:108031. [PMID: 34774879 DOI: 10.1016/j.pharmthera.2021.108031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 De Muynck K, Vanderborght B, Van Vlierberghe H, Devisscher L. The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective. Cells 2021;10:2959. [PMID: 34831182 DOI: 10.3390/cells10112959] [Reference Citation Analysis]
28 Zhao M, Chen C, Yuan Z, Li W, Zhang M, Cui N, Duan Y, Zhang X, Zhang P. Dietary Bacillus subtilis supplementation alleviates alcohol-induced liver injury by maintaining intestinal integrity and gut microbiota homeostasis in mice. Exp Ther Med 2021;22:1312. [PMID: 34630666 DOI: 10.3892/etm.2021.10747] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Kalo E, Read S, Ahlenstiel G. Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension. Livers 2021;1:147-79. [DOI: 10.3390/livers1030014] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Kong M, Dong W, Zhu Y, Fan Z, Miao X, Guo Y, Li C, Duan Y, Lu Y, Li Z, Xu Y. Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury. Redox Biol 2021;46:102079. [PMID: 34454163 DOI: 10.1016/j.redox.2021.102079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Jin J, Lin J, Xu A, Lou J, Qian C, Li X, Wang Y, Yu W, Tao H. CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment. Front Oncol 2021;11:722916. [PMID: 34386431 DOI: 10.3389/fonc.2021.722916] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
32 Roohani S, Tacke F. Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance. Int J Mol Sci 2021;22:7249. [PMID: 34298870 DOI: 10.3390/ijms22147249] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
33 Rasmussen EB, Eriksen LL, Greisen SR, Hansen AL, Carstensen M, Sandahl TD, Støy S, Kragstrup TW. Diminished Non-Classical Monocytes in the Blood Associate with Disease Severity in Alcoholic Hepatitis. Clin Exp Gastroenterol 2021;14:259-67. [PMID: 34135614 DOI: 10.2147/CEG.S299775] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Gao J, Wei B, Liu M, Hirsova P, Sehrawat TS, Cao S, Hu X, Xue F, Yaqoob U, Kang N, Cui H, Pomerantz WCK, Kostallari E, Shah VH. Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling. Hepatology 2021;73:2468-83. [PMID: 33159815 DOI: 10.1002/hep.31617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
35 Thanda Han MA, Pyrsopoulos N. Emerging Therapies for Alcoholic Hepatitis. Clin Liver Dis 2021;25:603-24. [PMID: 34229843 DOI: 10.1016/j.cld.2021.03.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Cao S, Liu M, Sehrawat TS, Shah VH. Regulation and functional roles of chemokines in liver diseases. Nat Rev Gastroenterol Hepatol 2021;18:630-47. [PMID: 33976393 DOI: 10.1038/s41575-021-00444-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
37 Cheng D, Chai J, Wang H, Fu L, Peng S, Ni X. Hepatic macrophages: Key players in the development and progression of liver fibrosis. Liver Int 2021. [PMID: 33966318 DOI: 10.1111/liv.14940] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
38 Acharya P, Chouhan K, Weiskirchen S, Weiskirchen R. Cellular Mechanisms of Liver Fibrosis. Front Pharmacol 2021;12:671640. [PMID: 34025430 DOI: 10.3389/fphar.2021.671640] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
39 Singanayagam A, Triantafyllou E. Macrophages in Chronic Liver Failure: Diversity, Plasticity and Therapeutic Targeting. Front Immunol 2021;12:661182. [PMID: 33868313 DOI: 10.3389/fimmu.2021.661182] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
40 New-Aaron M, Ganesan M, Dagur RS, Kharbanda KK, Poluektova LY, Osna NA. Pancreatogenic Diabetes: Triggering Effects of Alcohol and HIV. Biology (Basel) 2021;10:108. [PMID: 33546230 DOI: 10.3390/biology10020108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Liu M, Chen Y, Wang S, Zhou H, Feng D, Wei J, Shi X, Wu L, Zhang P, Yang H, Lv X. α-Ketoglutarate Modulates Macrophage Polarization Through Regulation of PPARγ Transcription and mTORC1/p70S6K Pathway to Ameliorate ALI/ARDS. Shock 2020;53:103-13. [PMID: 31841452 DOI: 10.1097/SHK.0000000000001333] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
42 Smith NC, Goulart C, Hayward JA, Kupz A, Miller CM, van Dooren GG. Control of human toxoplasmosis. Int J Parasitol 2021;51:95-121. [PMID: 33347832 DOI: 10.1016/j.ijpara.2020.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
43 Wang H, Mehal W, Nagy LE, Rotman Y. Immunological mechanisms and therapeutic targets of fatty liver diseases. Cell Mol Immunol 2021;18:73-91. [PMID: 33268887 DOI: 10.1038/s41423-020-00579-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
44 Wen B, Zhang C, Zhou J, Zhang Z, Che Q, Cao H, Bai Y, Guo J, Su Z. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacol Ther 2021;222:107752. [PMID: 33253739 DOI: 10.1016/j.pharmthera.2020.107752] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
45 Alharshawi K, Fey H, Vogle A, Klenk T, Kim M, Aloman C. Sex specific effect of alcohol on hepatic plasmacytoid dendritic cells. Int Immunopharmacol 2021;90:107166. [PMID: 33199233 DOI: 10.1016/j.intimp.2020.107166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
46 Yu HH, Qiu YX, Li B, Peng CY, Zeng R, Wang W. Kadsura heteroclita stem ethanol extract protects against carbon tetrachloride-induced liver injury in mice via suppression of oxidative stress, inflammation, and apoptosis. J Ethnopharmacol. 2021;267:113496. [PMID: 33091494 DOI: 10.1016/j.jep.2020.113496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Kimura T, Pydi SP, Pham J, Tanaka N. Metabolic Functions of G Protein-Coupled Receptors in Hepatocytes-Potential Applications for Diabetes and NAFLD. Biomolecules 2020;10:E1445. [PMID: 33076386 DOI: 10.3390/biom10101445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
48 Wen Y, Lambrecht J, Ju C, Tacke F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol 2021;18:45-56. [PMID: 33041338 DOI: 10.1038/s41423-020-00558-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 92] [Article Influence: 11.5] [Reference Citation Analysis]
49 Lowe PP, Morel C, Ambade A, Iracheta-Vellve A, Kwiatkowski E, Satishchandran A, Furi I, Cho Y, Gyongyosi B, Catalano D, Lefebvre E, Fischer L, Seyedkazemi S, Schafer DP, Szabo G. Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations. J Neuroinflammation 2020;17:296. [PMID: 33036616 DOI: 10.1186/s12974-020-01972-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
50 Li M, Chen L, Gao Y, Li M, Wang X, Qiang L, Wang X. Recent advances targeting C-C chemokine receptor type 2 for liver diseases in monocyte/macrophage. Liver Int 2020;40:2928-36. [PMID: 33025657 DOI: 10.1111/liv.14687] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
51 Tornai D, Szabo G. Emerging medical therapies for severe alcoholic hepatitis. Clin Mol Hepatol 2020;26:686-96. [PMID: 32981291 DOI: 10.3350/cmh.2020.0145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
52 Kondo R, Iwakiri Y. The lymphatic system in alcohol-associated liver disease. Clin Mol Hepatol 2020;26:633-8. [PMID: 32951411 DOI: 10.3350/cmh.2020.0179] [Reference Citation Analysis]
53 Diaz Soto MP, Lim JK. Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data. Hepat Med 2020;12:115-23. [PMID: 32884369 DOI: 10.2147/HMER.S230613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
54 Rinchai D, Syed Ahamed Kabeer B, Toufiq M, Tatari-Calderone Z, Deola S, Brummaier T, Garand M, Branco R, Baldwin N, Alfaki M, Altman MC, Ballestrero A, Bassetti M, Zoppoli G, De Maria A, Tang B, Bedognetti D, Chaussabel D. A modular framework for the development of targeted Covid-19 blood transcript profiling panels. J Transl Med 2020;18:291. [PMID: 32736569 DOI: 10.1186/s12967-020-02456-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
55 Liu Y, Wang Z, Kong F, Teng L, Zheng X, Liu X, Wang D. Triterpenoids Extracted From Antrodia cinnamomea Mycelia Attenuate Acute Alcohol-Induced Liver Injury in C57BL/6 Mice via Suppression Inflammatory Response. Front Microbiol 2020;11:1113. [PMID: 32719658 DOI: 10.3389/fmicb.2020.01113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
56 Huang E, Peng N, Xiao F, Hu D, Wang X, Lu L. The Roles of Immune Cells in the Pathogenesis of Fibrosis. Int J Mol Sci 2020;21:E5203. [PMID: 32708044 DOI: 10.3390/ijms21155203] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
57 Kwiatkowski K, Ciapała K, Rojewska E, Makuch W, Mika J. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses. Int Immunopharmacol 2020;84:106540. [PMID: 32402949 DOI: 10.1016/j.intimp.2020.106540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
58 Puengel T, De Vos S, Hundertmark J, Kohlhepp M, Guldiken N, Pujuguet P, Auberval M, Marsais F, Shoji KF, Saniere L, Trautwein C, Luedde T, Strnad P, Brys R, Clément-Lacroix P, Tacke F. The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis. J Clin Med 2020;9:E1140. [PMID: 32316235 DOI: 10.3390/jcm9041140] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
59 Avila MA, Dufour JF, Gerbes AL, Zoulim F, Bataller R, Burra P, Cortez-Pinto H, Gao B, Gilmore I, Mathurin P, Moreno C, Poznyak V, Schnabl B, Szabo G, Thiele M, Thursz MR. Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting. Gut 2020;69:764-80. [PMID: 31879281 DOI: 10.1136/gutjnl-2019-319720] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 23.0] [Reference Citation Analysis]
60 Queck A, Bode H, Uschner FE, Brol MJ, Graf C, Schulz M, Jansen C, Praktiknjo M, Schierwagen R, Klein S, Trautwein C, Wasmuth HE, Berres ML, Trebicka J, Lehmann J. Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis. Front Immunol 2020;11:354. [PMID: 32218781 DOI: 10.3389/fimmu.2020.00354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
61 Trivella JP, Martin P, Carrion AF. Novel targeted therapies for the management of liver fibrosis. Expert Opinion on Emerging Drugs 2020;25:59-70. [DOI: 10.1080/14728214.2020.1735350] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
62 She S, Wu X, Zheng D, Pei X, Ma J, Sun Y, Zhou J, Nong L, Guo C, Lv P, Song Q, Zheng C, Liang W, Huang S, Li Q, Liu Z, Song Z, Li Y, Zhang Y, Kong W, You H, Xi J, Wang Y. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target. Journal of Hepatology 2020;72:506-18. [DOI: 10.1016/j.jhep.2019.09.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
63 Xu W, Chen S, Zhong G, Liu H, Xiu L, Yu X, Chen F, Li N, Lv Y. Effects of a combination of Japanese Raisin Tree Seed and Flower of Lobed Kudzuvine against acute alcohol-induced liver injury in mice. Journal of Traditional Chinese Medical Sciences 2020;7:59-67. [DOI: 10.1016/j.jtcms.2020.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Hachim MY, Khalil BA, Elemam NM, Maghazachi AA. Pyroptosis: The missing puzzle among innate and adaptive immunity crosstalk. J Leukoc Biol 2020;108:323-38. [PMID: 32083338 DOI: 10.1002/JLB.3MIR0120-625R] [Cited by in Crossref: 10] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
65 Zhang K, Shi Z, Zhang M, Dong X, Zheng L, Li G, Han X, Yao Z, Han T, Hong W. Silencing lncRNA Lfar1 alleviates the classical activation and pyoptosis of macrophage in hepatic fibrosis. Cell Death Dis. 2020;11:132. [PMID: 32071306 DOI: 10.1038/s41419-020-2323-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
66 Lefere S, Devisscher L, Tacke F. Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges. Expert Opin Investig Drugs 2020;29:89-92. [PMID: 31952447 DOI: 10.1080/13543784.2020.1718106] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
67 Miao M, De Clercq E, Li G. Clinical significance of chemokine receptor antagonists. Expert Opin Drug Metab Toxicol 2020;16:11-30. [PMID: 31903790 DOI: 10.1080/17425255.2020.1711884] [Cited by in Crossref: 31] [Cited by in F6Publishing: 46] [Article Influence: 15.5] [Reference Citation Analysis]
68 Lowe PP, Cho Y, Tornai D, Coban S, Catalano D, Szabo G. Inhibition of the Inflammasome Signaling Cascade Reduces Alcohol Consumption in Female But Not Male Mice. Alcohol Clin Exp Res 2020;44:567-78. [PMID: 31854009 DOI: 10.1111/acer.14272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
69 Xiao M, Liu Y, Wang L, Liang J, Wang T, Zhai Y, Wang Y, Liu S, Liu W, Luo X, Wang F, Sun X. Intraocular VEGF deprivation induces degeneration and fibrogenic response in retina. The FASEB Journal 2019;33:13920-34. [DOI: 10.1096/fj.201901283rr] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
70 Zhangdi HJ, Su SB, Wang F, Liang ZY, Yan YD, Qin SY, Jiang HX. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol 2019; 25(33): 4835-4849 [PMID: 31543677 DOI: 10.3748/wjg.v25.i33.4835] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 9.7] [Reference Citation Analysis]
71 Fantuzzi L, Tagliamonte M, Gauzzi MC, Lopalco L. Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders. Cell Mol Life Sci 2019;76:4869-86. [PMID: 31377844 DOI: 10.1007/s00018-019-03255-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 10.7] [Reference Citation Analysis]
72 Kong LZ, Chandimali N, Han YH, Lee DH, Kim JS, Kim SU, Kim TD, Jeong DK, Sun HN, Lee DS, Kwon T. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease. Int J Mol Sci 2019;20:E2712. [PMID: 31159489 DOI: 10.3390/ijms20112712] [Cited by in Crossref: 31] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
73 Kim SJ, Feng D, Guillot A, Dai S, Liu F, Hwang S, Parker R, Seo W, He Y, Godlewski G, Jeong WI, Lin Y, Qin X, Kunos G, Gao B. Adipocyte Death Preferentially Induces Liver Injury and Inflammation Through the Activation of Chemokine (C-C Motif) Receptor 2-Positive Macrophages and Lipolysis. Hepatology 2019;69:1965-82. [PMID: 30681731 DOI: 10.1002/hep.30525] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
74 Bluemel S, Wang L, Kuelbs C, Moncera K, Torralba M, Singh H, Fouts DE, Schnabl B. Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice. Gut Microbes 2020;11:265-75. [PMID: 30982395 DOI: 10.1080/19490976.2019.1595300] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
75 Ohtani N, Kawada N. Role of the Gut-Liver Axis in Liver Inflammation, Fibrosis, and Cancer: A Special Focus on the Gut Microbiota Relationship. Hepatol Commun. 2019;3:456-470. [PMID: 30976737 DOI: 10.1002/hep4.1331] [Cited by in Crossref: 33] [Cited by in F6Publishing: 54] [Article Influence: 11.0] [Reference Citation Analysis]